{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T12:28:18Z","timestamp":1725971298002},"publisher-location":"New York, NY","reference-count":21,"publisher":"Springer New York","isbn-type":[{"type":"print","value":"9781493976485"},{"type":"electronic","value":"9781493976492"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-1-4939-7649-2_11","type":"book-chapter","created":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T11:12:41Z","timestamp":1521112361000},"page":"161-173","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Generation and Use of Merlin-Deficient Human Schwann Cells for a High-Throughput Chemical Genomics Screening Assay"],"prefix":"10.1007","author":[{"given":"Alejandra M.","family":"Petrilli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Fern\u00e1ndez-Valle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,16]]},"reference":[{"issue":"6429","key":"11_CR1","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/363515a0","volume":"363","author":"GA Rouleau","year":"1993","unstructured":"Rouleau GA, Merel P, Lutchman M, Sanson M, Zucman J, Marineau C, Hoang-Xuan K, Demczuk S, Desmaze C, Plougastel B et al (1993) Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 363(6429):515\u2013521. \nhttps:\/\/doi.org\/10.1038\/363515a0","journal-title":"Nature"},{"issue":"4","key":"11_CR2","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/0092-8674(93)90501-G","volume":"75","author":"JA Trofatter","year":"1993","unstructured":"Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyao MP, Parry DM, Eldridge R, Kley N, Menon AG, Pulaski K et al (1993) A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 75(4):826","journal-title":"Cell"},{"issue":"11","key":"11_CR3","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/ng.3688","volume":"48","author":"S Agnihotri","year":"2016","unstructured":"Agnihotri S, Jalali S, Wilson MR, Danesh A, Li M, Klironomos G, Krieger JR, Mansouri A, Khan O, Mamatjan Y, Landon-Brace N, Tung T, Dowar M, Li T, Bruce JP, Burrell KE, Tonge PD, Alamsahebpour A, Krischek B, Agarwalla PK, Bi WL, Dunn IF, Beroukhim R, Fehlings MG, Bril V, Pagnotta SM, Iavarone A, Pugh TJ, Aldape KD, Zadeh G (2016) The genomic landscape of schwannoma. Nat Genet 48(11):1339\u20131348. \nhttps:\/\/doi.org\/10.1038\/ng.3688","journal-title":"Nat Genet"},{"issue":"6080","key":"11_CR4","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/322644a0","volume":"322","author":"BR Seizinger","year":"1986","unstructured":"Seizinger BR, Martuza RL, Gusella JF (1986) Loss of genes on chromosome 22 in tumorigenesis of human acoustic neuroma. Nature 322(6080):644\u2013647. \nhttps:\/\/doi.org\/10.1038\/322644a0","journal-title":"Nature"},{"issue":"5","key":"11_CR5","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/onc.2015.125","volume":"35","author":"AM Petrilli","year":"2016","unstructured":"Petrilli AM, Fernandez-Valle C (2016) Role of Merlin\/NF2 inactivation in tumor biology. Oncogene 35(5):537\u2013548. \nhttps:\/\/doi.org\/10.1038\/onc.2015.125","journal-title":"Oncogene"},{"issue":"5","key":"11_CR6","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1093\/neuonc\/nov200","volume":"18","author":"JO Blakeley","year":"2016","unstructured":"Blakeley JO, Plotkin SR (2016) Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis. Neuro-Oncology 18(5):624\u2013638. \nhttps:\/\/doi.org\/10.1093\/neuonc\/nov200","journal-title":"Neuro-Oncology"},{"key":"11_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1750-1172-4-16","volume":"4","author":"DG Evans","year":"2009","unstructured":"Evans DG (2009) Neurofibromatosis type 2 (NF2): a clinical and molecular review. Orphanet J Rare Dis 4:16. \nhttps:\/\/doi.org\/10.1186\/1750-1172-4-16","journal-title":"Orphanet J Rare Dis"},{"key":"11_CR8","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/0014-4827(65)90211-9","volume":"37","author":"L Hayflick","year":"1965","unstructured":"Hayflick L (1965) The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 37:614\u2013636","journal-title":"Exp Cell Res"},{"issue":"2","key":"11_CR9","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1097\/01.mao.0000247811.93453.6a","volume":"28","author":"S Nair","year":"2007","unstructured":"Nair S, Leung H, Collins A, Ramsden R, Wilson J (2007) Primary cultures of human vestibular schwannoma: selective growth of schwannoma cells. Otol Neurotol 28(2):258\u2013263. \nhttps:\/\/doi.org\/10.1097\/01.mao.0000247811.93453.6a","journal-title":"Otol Neurotol"},{"issue":"1","key":"11_CR10","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/nm0195-80","volume":"1","author":"JL Rutkowski","year":"1995","unstructured":"Rutkowski JL, Kirk CJ, Lerner MA, Tennekoon GI (1995) Purification and expansion of human Schwann cells in vitro. Nat Med 1(1):80\u201383","journal-title":"Nat Med"},{"key":"11_CR11","first-page":"173","volume":"107","author":"VJ Turnbull","year":"2005","unstructured":"Turnbull VJ (2005) Culturing human Schwann cells. Methods Mol Med 107:173\u2013182","journal-title":"Methods Mol Med"},{"key":"11_CR12","doi-asserted-by":"publisher","first-page":"620834","DOI":"10.1155\/2012\/620834","volume":"2012","author":"VW Keng","year":"2012","unstructured":"Keng VW, Watson AL, Rahrmann EP, Li H, Tschida BR, Moriarity BS, Choi K, Rizvi TA, Collins MH, Wallace MR, Ratner N, Largaespada DA (2012) Conditional inactivation of Pten with EGFR overexpression in Schwann cells models sporadic MPNST. Sarcoma 2012:620834. \nhttps:\/\/doi.org\/10.1155\/2012\/620834","journal-title":"Sarcoma"},{"issue":"3","key":"11_CR13","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1089\/scd.2010.0513","volume":"21","author":"HC Lehmann","year":"2012","unstructured":"Lehmann HC, Chen W, Mi R, Wang S, Liu Y, Rao M, Hoke A (2012) Human Schwann cells retain essential phenotype characteristics after immortalization. Stem Cells Dev 21(3):423\u2013431. \nhttps:\/\/doi.org\/10.1089\/scd.2010.0513","journal-title":"Stem Cells Dev"},{"issue":"3","key":"11_CR14","first-page":"475","volume":"20","author":"G Hung","year":"2002","unstructured":"Hung G, Li X, Faudoa R, Xeu Z, Kluwe L, Rhim JS, Slattery W, Lim D (2002) Establishment and characterization of a schwannoma cell line from a patient with neurofibromatosis 2. Int J Oncol 20(3):475\u2013482","journal-title":"Int J Oncol"},{"issue":"1\u20132","key":"11_CR15","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.mrfmmm.2007.07.015","volume":"637","author":"P Lepont","year":"2008","unstructured":"Lepont P, Stickney JT, Foster LA, Meng JJ, Hennigan RF, Ip W (2008) Point mutation in the NF2 gene of HEI-193 human schwannoma cells results in the expression of a merlin isoform with attenuated growth suppressive activity. Mutat Res 637(1\u20132):142\u2013151. \nhttps:\/\/doi.org\/10.1016\/j.mrfmmm.2007.07.015","journal-title":"Mutat Res"},{"issue":"5","key":"11_CR16","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1212\/WNL.54.5.1132","volume":"54","author":"M Sainio","year":"2000","unstructured":"Sainio M, Jaaskelainen J, Pihlaja H, Carpen O (2000) Mild familial neurofibromatosis 2 associates with expression of merlin with altered COOH-terminus. Neurology 54(5):1132\u20131138","journal-title":"Neurology"},{"issue":"5","key":"11_CR17","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/sj.cgt.7701037","volume":"14","author":"S Prabhakar","year":"2007","unstructured":"Prabhakar S, Messerli SM, Stemmer-Rachamimov AO, Liu TC, Rabkin S, Martuza R, Breakefield XO (2007) Treatment of implantable NF2 schwannoma tumor models with oncolytic herpes simplex virus G47Delta. Cancer Gene Ther 14(5):460\u2013467. \nhttps:\/\/doi.org\/10.1038\/sj.cgt.7701037","journal-title":"Cancer Gene Ther"},{"issue":"2","key":"11_CR18","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.nbd.2007.09.002","volume":"29","author":"MF James","year":"2008","unstructured":"James MF, Lelke JM, Maccollin M, Plotkin SR, Stemmer-Rachamimov AO, Ramesh V, Gusella JF (2008) Modeling NF2 with human arachnoidal and meningioma cell culture systems: NF2 silencing reflects the benign character of tumor growth. Neurobiol Dis 29(2):278\u2013292. \nhttps:\/\/doi.org\/10.1016\/j.nbd.2007.09.002","journal-title":"Neurobiol Dis"},{"issue":"6166","key":"11_CR19","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.1247005","volume":"343","author":"O Shalem","year":"2014","unstructured":"Shalem O, Sanjana NE, Hartenian E, Shi X, Scott DA, Mikkelsen TS, Heckl D, Ebert BL, Root DE, Doench JG, Zhang F (2014) Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343(6166):84\u201387. \nhttps:\/\/doi.org\/10.1126\/science.1247005","journal-title":"Science"},{"issue":"5","key":"11_CR20","first-page":"471","volume":"6","author":"AM Petrilli","year":"2014","unstructured":"Petrilli AM, Fuse MA, Donnan MS, Bott M, Sparrow NA, Tondera D, Huffziger J, Frenzel C, Malany CS, Echeverri CJ, Smith L, Fernandez-Valle C (2014) A chemical biology approach identified PI3K as a potential therapeutic target for neurofibromatosis type 2. Am J Transl Res 6(5):471\u2013493","journal-title":"Am J Transl Res"},{"issue":"2","key":"11_CR21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","volume":"4","author":"JH Zhang","year":"1999","unstructured":"Zhang JH, Chung TD, Oldenburg KR (1999) A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 4(2):67\u201373","journal-title":"J Biomol Screen"}],"container-title":["Methods in Molecular Biology","Schwann Cells"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-7649-2_11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T11:13:56Z","timestamp":1521112436000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-7649-2_11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9781493976485","9781493976492"],"references-count":21,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-7649-2_11","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2018]]}}}